Literature DB >> 30297140

Participant satisfaction with dementia prevention research: Results from Home-Based Assessment trial.

Mary Sano1, Susan Egelko2, Carolyn W Zhu3, Clara Li2, Michael C Donohue4, Steven Ferris5, Jeffrey Kaye6, James C Mundt7, Chung-Kai Sun4, Paul S Aisen4, Howard H Feldman8.   

Abstract

INTRODUCTION: Little is known about factors affecting motivation and satisfaction of participants in dementia prevention trials.
METHODS: A Research Satisfaction Survey was administered to 422 nondemented older adults who participated in the Home-Based Assessment trial.
RESULTS: Overall satisfaction was high, with means of all individual items near to above a value of 3 on a scale from 1 (worst) to 4 (best). Greater satisfaction was associated with staff-administered interviews versus automated technologies. The most liked aspects of research participation were volunteerism, opportunity to challenge and improve mental function, and positive interactions with staff. The least liked aspect was repetitiveness of the assessments. Participants requested more contact with staff and other older adults and more feedback on performance. DISCUSSION: Older adults' participation in research was primarily motivated by altruism. Methodologies that facilitate human contact, encourage feedback and novelty of tasks should be incorporated into future trial design.
Copyright © 2018 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical Trial; Dementia prevention; Home-based assessment; Research satisfaction; Technology

Mesh:

Year:  2018        PMID: 30297140     DOI: 10.1016/j.jalz.2018.05.016

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  5 in total

Review 1.  Ethical Considerations in Communicating Alzheimer's Disease Neuroimaging Biomarker Test Results to Symptomatic Individuals.

Authors:  Daniel A Wilkenfeld; Staci L Orbell; Jennifer H Lingler
Journal:  Neurotherapeutics       Date:  2021-04-15       Impact factor: 7.620

Review 2.  Adapting Alzheimer Disease and Related Dementias Clinical Research Evaluations in the Age of COVID-19.

Authors:  Maria Loizos; Judith Neugroschl; Carolyn W Zhu; Clara Li; Margaret Sewell; Michael T Kinsella; Amy Aloysi; Hillel Grossman; Corbett Schimming; Jane Martin; Mary Sano
Journal:  Alzheimer Dis Assoc Disord       Date:  2021 Apr-Jun 01       Impact factor: 2.703

3.  Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force.

Authors:  J Kaye; P Aisen; R Amariglio; R Au; C Ballard; M Carrillo; H Fillit; T Iwatsubo; G Jimenez-Maggiora; S Lovestone; F Natanegara; K Papp; M E Soto; M Weiner; B Vellas
Journal:  J Prev Alzheimers Dis       Date:  2021

4.  Impact of potential modifications to Alzheimer's disease clinical trials in response to disruption by COVID-19: a simulation study.

Authors:  Lon S Schneider; Yuqi Qiu; Ronald G Thomas; Carol Evans; Diane M Jacobs; Shelia Jin; Jeffrey A Kaye; Andrea Z LaCroix; Karen Messer; David P Salmon; Mary Sano; Kimberly Schafer; Howard H Feldman
Journal:  Alzheimers Res Ther       Date:  2021-12-20       Impact factor: 6.982

5.  Feasibility and Acceptability of a Dietary Intervention to Reduce Salt Intake and Increase High-Nitrate Vegetable Consumption in Malaysian Middle-Aged and Older Adults with Elevated Blood Pressure: Findings from the DePEC-Nutrition Trial.

Authors:  Siew Siew Lee; Andrea McGrattan; Yee Chang Soh; Mawada Alawad; Tin Tin Su; Uma Devi Palanisamy; Azizah Mat Hussin; Zaid Bin Kassim; Ahmad Nizal Bin Mohd Ghazali; Blossom Christa Maree Stephan; Pascale Allotey; Daniel D Reidpath; Louise Robinson; Devi Mohan; Mario Siervo
Journal:  Nutrients       Date:  2022-01-19       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.